The Therapeutic Goods Administration (TGA) has launched a web hub to help consumers and health professionals find information on transvaginal (urogynaecological) surgical mesh. The web hub links to information on consumer support services, adverse event reporting, regulatory changes, the Senate Inquiry into transvaginal mesh, and other topics.
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists has information on use of mesh for treatment of pelvic organ prolapse available on its website. The College is currently reviewing its information on use of mesh for treatment of stress urinary incontinence.
The Urogynaecological Society of Australasia also has a range of information available for patients on pelvic organ prolapse and stress urinary incontinence and treatment options.
The Commission has developed Top Tips for Safe Health Care to help consumers, their families, carers and other support people get the most out of their health care. The booklet includes information on providing feedback to healthcare providers and organisations and making and resolving complaints.
The Therapeutic Goods Administration has information on its web site about mesh complications, reporting of complications and action it has taken in relation to mesh.
The Australian Senate Community Affairs References Committee led an inquiry into the number of women in Australia who have had transvaginal mesh implants and related matters. More information is available here.